Las Vegas, NV -- (SBWIRE) -- 01/17/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: J.C. Penney Company, Inc.(NYSE:JCP), Delcath Systems, Inc.(NASDAQ:DCTH), Office Depot Inc(NYSE:ODP), Rexahn Pharmaceuticals, Inc.(NYSEMKT:RNN)
J.C. Penney Company, Inc. (NYSE:JCP) was a volume gainer of 43.79 million shares and the average volume of the stock remained 28.78 million shares. The stock opened the session at $6.65 and finished at the end of the day at $6.90 and the stock plunged -1.57%.The market capitalization of the stock remained 2.10 billion. J. C. Penney Company, Inc., through its subsidiary, J. C. Penney Corporation, Inc., operates department stores. The company sells family apparel and footwear, accessories, fine and fashion jewelry, beauty products, and home furnishings.
Has JCP Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Delcath Systems, Inc. (NASDAQ:DCTH) exchanged 27.84 million shares and the average volume remained 4.41 million shares. The stock closed the session at $0.390 with the gain of 30.96%. Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on the field of oncology. Delcath Systems, Inc. was founded in 1988 and is headquartered in Queensbury, New York.
Will DCTH Continue To Move Higher? Find Out Here
Office Depot Inc (NYSE:ODP) decreased -1.45% and its closing price was $4.77. The volume of the stock was 27.66 million shares and the average volume remained 8.75 million shares. The market capitalization of the stock remained 2.53 billion. The beta of the stock remained 3.78. Office Depot, Inc., together with its subsidiaries, supplies office products and services. Office Depot, Inc. was founded in 1986 and is headquartered in Boca Raton, Florida.
Will ODP Get Buyers Even After The Recent Rally? Find Out Here
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) exchanged 25.60 million shares in the previous trading session, and its average trading remained 9.83 million shares. RNN advanced 7.69% and it closed the trading at $1.12. The market capitalization of the stock remained 164.32 million. Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for cancer, central nervous system disorders, sexual dysfunction, and other medical needs.
For How Long RNN’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/">http://www.equityobserver.com/&l...; employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/>
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)